RecruitingNot ApplicableNCT06915831
Type 1 Diabetes and Obstructive Sleep Apnea
Obstructive Sleep Apnea and Glycemic Dysregulation in Adults With Type 1 Diabetes
Sponsor
University of Chicago
Enrollment
40 participants
Start Date
Nov 10, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
Eligibility
Min Age: 18 YearsMax Age: 50 Years
Plain Language Summary
Simplified for easier understanding
This study is looking at the relationship between Type 1 Diabetes and obstructive sleep apnea (a condition where breathing repeatedly stops during sleep). Researchers want to understand how sleep apnea affects blood sugar control overnight in people using an insulin pump and continuous glucose monitor.
**You may be eligible if...**
- You are between 18 and 50 years old
- You have Type 1 Diabetes and use both an insulin pump and a continuous glucose monitor
- Your average blood sugar control (GMI) falls between 5.5% and 8.5%
- You have been diagnosed with obstructive sleep apnea (confirmed by a home sleep test)
**You may NOT be eligible if...**
- You are already regularly using a CPAP machine for sleep apnea
- You have had a near-miss driving accident due to sleepiness in the past 6 months
- You have had severe low blood sugar episodes in the past 3 months
- You have had a heart attack or stroke in the past 6 months
- You have advanced kidney disease, proliferative eye disease, or severe high blood pressure
- You work night shifts
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEContinuous positive airway pressure (CPAP)
All-night CPAP will be applied with bedtimes 23:00h to 7:00h.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06915831
Related Trials
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
NCT07369011123 locations
Home Apnea Testing in CHildren Trial
NCT053827541 location
Kidney Precision Medicine Project
NCT0433470713 locations
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
NCT0691935410 locations
Capillary OGTT Study
NCT068150814 locations